Dynamic positron tomographic imaging with nitrogen-13 glutamate in patients with coronary artery disease: comparison with nitrogen-13 ammonia and fluorine-18 fluorodeoxyglucose imaging.

[1]  M E Phelps,et al.  13N ammonia myocardial imaging at rest and with exercise in normal volunteers. Quantification of absolute myocardial perfusion with dynamic positron emission tomography. , 1989, Circulation.

[2]  Michael E. Phelps,et al.  Semiautomatic Software For Quantitative Analysis Of Cardiac Positron Tomography Studies , 1988, Medical Imaging.

[3]  F. Neumann,et al.  Regional myocardial nitrogen-13 glutamate uptake in patients with coronary artery disease: inverse post-stress relation to thallium-201 uptake in ischemia. , 1988, Journal of the American College of Cardiology.

[4]  J. Barrio,et al.  Effects of anoxia on kinetics of [13N] glutamate and 13NH3 metabolism in rabbit myocardium. , 1987, Circulation research.

[5]  J. Barrio,et al.  Nitrogen-13 flux from L-[13N]glutamate in the isolated rabbit heart: effect of substrates and transaminase inhibition. , 1986, Biochimica et biophysica acta.

[6]  Michael E. Phelps,et al.  Dynamic, Gated and High Resolution Imaging with the ECAT III , 1986, IEEE Transactions on Nuclear Science.

[7]  G. Buckberg,et al.  Safety of prolonged aortic clamping with blood cardioplegia. II. Glutamate enrichment in energy-depleted hearts. , 1984, The Journal of thoracic and cardiovascular surgery.

[8]  J. Barrio,et al.  Synthesis and myocardial kinetics of N-13 and C-11 labeled branched-chain L-amino acids. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  K. Shine,et al.  Protection of ischemic rabbit myocardium by glutamic acid. , 1983, The American journal of physiology.

[10]  M E Phelps,et al.  Identification and Differentiation of Resting Myocardial Ischemia and Infarction in Man with Positron Computed Tomography, 18F‐labeled Fluorodeoxyglucose and N‐13 Ammonia , 1983, Circulation.

[11]  J. Barrio,et al.  Evaluation of myocardial metabolism, with N-13- and C-11-labeled amino acids and positron computed tomography. , 1982, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  J. Barrio,et al.  13N-labeled L-amino acids for in vivo assessment of local myocardial metabolism. , 1981, Journal of medicinal chemistry.

[13]  D. Kuhl,et al.  N‐13 Ammonia as an Indicator of Myocardial Blood Flow , 1981, Circulation.

[14]  G. Buckberg,et al.  Reversal of ischemic damage with amino acid substrate enhancement during reperfusion. , 1980, Surgery.

[15]  J. S. Laughlin,et al.  Imaging of the human heart after administration of L-(N-13)glutamate. , 1980, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[16]  K. Shine,et al.  Enhanced mechanical recovery of anoxic and ischemic myocardium by amino acid perfusion. , 1979, The American journal of physiology.

[17]  E. Hoffman,et al.  Regional myocardial perfusion assessed with N-13 labeled ammonia and positron emission computerized axial tomography. , 1979, The American journal of cardiology.

[18]  R. M. Mills,et al.  Alterations of myocardial amino acid metabolism in chronic ischemic heart disease. , 1976, The Journal of clinical investigation.

[19]  S. C. Huang,et al.  Validation of PET..Acquired Input Functions for CardiacStudies , 2006 .

[20]  N Satyamurthy,et al.  Computer-controlled radiochemical synthesis: a chemistry process control unit for the automated production of radiochemicals. , 1989, International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes.

[21]  T. Nielsen,et al.  Myocardial exchanges of glutamate, alanine and citrate in controls and patients with coronary artery disease. , 1983, Clinical science.

[22]  N. Macdonald,et al.  Nitrogen-13-labeled ammonia for multiple daily needs in a nuclear medicine clinic , 1979 .